Reduced susceptibility of magnocellular neuroendocrine nuclei of the rat hypothalamus to transient focal ischemia produced by middle cerebral artery occlusion

Experimental Neurology

Volumn 178, Issue 2, 2002, Pages 268-279

  Currás Collazo, Margarita C ^a   Patel, Urvish B ^a   Hussein, Mohamed O ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cleveland Chiropractic College   (United States)

Author keywords

Excitotoxicity; Neuroprotection; Osmoregulation; Paraventricular nucleus; Stroke; Supraoptic nucleus; Survival; Vasopressin

Indexed keywords

INDIAN INK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CELL POPULATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; GIANT CELL; GLIA CELL; HYPOTHALAMUS; MAGNOCELLULAR NUCLEUS; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; OPTICAL DENSITY; PARIETAL LOBE; PERFUSION; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; TISSUE SECTION;

EID: 0036939072     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.8032     Document Type: Article

References (59)

1. Garcia, J. H., K. F. Liu, and K. L. Ho. 1995. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the CP and the cortex. Stroke 26 (4): 636-642.
2. Tamura, A., D. I. Graham, J. McCulloch, and G. M. Teasdale. 1981. Focal cerebral ischemia in the rat. I: Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1: 53-60.
3. Zea Longa, E., P. R. Weinstein, S. Carlson, and R. Cummins. 1989. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20: 84-91.
4. Nagasawa, H., and K. Kogure. 1989. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20: 1037-1043.
5. Bederson, J. B., L. H. Pitts, M. Tsuji, M. C. Nishimura, R. L. Davis, and H. Bartkowski. 1986. Middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17(3): 472-476.
6. Buchan, A. M., D. Xue, and A. Slivka. 1992b. A new model of temporary focal neocortical ischemia in the rat. Stroke 23: 273-279.
7. Ikonomidou, C., M. T. Price, J. L. Mosinger, G. Frierdich, J. Labruyere, K. Shahid Salles, and J. W. Olney. 1989. Hypobaricischemic conditions produce glutamate-like cytopathology in infant rat brain. J. Neurosci. 9(5): 1693-1700.
8. Garcia, J. H., Y. Yoshida, H. Chen, Y. Li, Z. G. Zhang, J. Lian, S. Chen, and M. Chopp. 1993. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol. 142: 623-635.
9. Zhang, R.-L., M. Chopp, H. Chen, and J. H. Garcia. 1994. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125: 3-10.
10. Ambach, G., and M. Palkovits. 1974. Blood supply of the rat hypothalamus: I. Nucleus supraopticus. Acta Morphol. Acad. Sci. Hung. 22(3-4): 291-310.
11. Ambach, G., and M. Palkovits. 1974. Blood supply of the rat hypothalamus: II. Nucleus paraventricularis. Acta Morphol. Acad. Sci. Hung. 22(3-4): 311-320.
12. Robinson, I. C. A. F. 1983. Neurohypophysial peptides in cere-brospinal fluid. In The Neurohypophysis: Structure, Function and Control (B. A. Cross and G. Leng, Eds.), Vol. 60, pp. 129-145. Elsevier, Amsterdam.
13. Roberts, J. S. 1977. Oxytocin. Eden Press, Montreal.
14. Shrier, R. W. 1985. Vasopressin. Raven Press, New York.
15. Dyball, R. E. J., and P. S. Poutney. 1973. Discharge patterns of supraoptic and paraventricular neurones in rats given 2% NaCl solution instead of drinking water. J. Endocrinol. 56: 91-98.
16. Dutton, A., and R. E. J. Dyball. 1979. Phasic firing enhances vasopressin release from the rat neurohypophysis. J. Physiol. 290: 433-440.
17. Sjoquist, M., W. Huang, E. Jacobsson, O. Skott, E. M. Stricker, and A. F. Sved. 1999. Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats. Endocrinology 140(6): 2814-2818.
18. Brimble, M. J., R. E. J. Dyball, and M. L. Forsling. 1978. Oxytocin release following osmotic activation of oxytocin neurones in the paraventricular and supraoptic nuclei. J. Physiol. 278: 69-78.
19. Nadler, J. V., B. W. Perry., and C. W. Cotman. 1978. Intraventricular kainic acid preferentially destroys hippocampal cells. Nature 271: 676-677.
20. Hu, B., T. Cunningham, R. Nissen, L. P. Renaud, and C. W. Bourque. 1992. Rat supraoptic neurons are resistant to glutamate neurotoxicity. NeuroReport 3: 87-90.
21. Olney, J. W., and T. de Gubareff. 1978. Extreme sensitivity of olfactory cortical neurons to kainic acid toxicity. Kainic Acid as a Tool in Neurobiology (E. G. McGeer et al., Eds.), pp. 201-217. Raven Press, New York.
22. Peterson, G. M., and R. Y. Moore. 1980. Selective effects of kainic acid on diencephalic neurons. Brain Res. 202: 165-182.
23. Herman, J. P., and S. J. Wiegand. 1986. Ibotenate-induced cell death in the hypothalamic paraventricular nucleus: Differential susceptibility of magnocellular and parvicellular neurons. Brain Res. 383: 367-372.
24. Hastings, M. H., P. Winn, and S. B. Dunnett. 1985. Neurotoxic amino acid lesions of the lateral hypothalamus: A parametric comparison of the effects of ibotenate, N-methyl-D-aspartate and quisqualate in the rat. Brain Res. 360: 248-256.
25. Olney, J. W., and L. G. Sharpe. 1969. Brain lesion in an infant rhesus monkey treated with monosodium glutamate. Science 166: 386-388.
26. Garcia, J. H., S. Wagner, K.-F. Liu, and X.-J. Hu. 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26: 627-635.
27. Hussein, M. O., and M. C. Currás-Collazo. 1998. Middle cerebral artery occlusion is effective in producing ischemia of the supraoptic and paraventricular nuclei of the hypothalamus. J. Vasc. Res. 35 (Suppl. 3): 8-9.
28. Coyle, P. 1975. Arterial patterns of the rat rhinencephalon and related structures. Exp. Neurol. 49(3): 671-690.
29. Smithson, K. G., B. A. MacVicar, and G. I. Hatton. 1983. Polyethylene glycol embedding: A technique compatible with immu-nocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J. Neurosci. Methods 7(1): 27-41.
30. St. Jacques, R., W. Gorczyca, and G. Mohr. 1996. Microvascular anatomy of striate vessels in dogs: Contribution to an experimental model of forebrain ischemia. Neurol. Res. 18(2): 157-162.
31. Pulsinelli, W. A., and J. B. Brierly. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10(3): 267-272.
32. Rieke, G. K., D. E. Bowers, and P. Penn. 1981. Vascular supply pattern to rat caudatoputamen and globus pallidus: Scanning electronmicroscopic study of vascular endocasts of stroke-prone vessels. Stroke 12(6): 840-847.
33. Coyle, P., and P. T. Jokelainen. 1982. Dorsal cerebral arterial collaterals of the rat. Anat. Rec. 203(3): 397-404.
34. Lee, R. M. 1995. Morphology of cerebral arteries. Pharmacol. Ther. 66(1): 149-73.
35. Drummond, J. C., Y.-S. Oh, D. J. Cole, and H. M. Shapiro. 1989. Phenylephrine-induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke 20: 1538-1544.
36. Salgado, A. V., S. C. Jones, A. J. Furlan, E. Korfali, S. A. Marshall, and J. R. Little. 1989. Bimodal treatment with nimodipine and low-molecular-weight dextran for focal cerebral ischemia in the rat. Ann. Neurol. 26(5): 621-7.
37. Kaplan, B., S. Brint, J. Tanabe, M. Jacewicz, X.-J. Wang, and W. Pulsinelli. 1991. Temporal thresholds for neocortical infarction in rats subjected to reversible cerebral ischemia. Stroke 22: 1032-1039.
38. Tyson, G. W., G. M. Teasdale, D. I. Graham, and J. McCullogh. 1984. Focal cerebral ischemia in the rat: Topography of hemodynamic and histopathological changes. Ann. Neurol. 15: 559-567.
39. Benveniste, H., J. Drejer, A. Schousboe, and N. H. Diemer. 1984. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43(5): 1369-1374.
40. Globus, M. Y., R. Busto, W. D. Dietrich, E. Martinez, I. Valdes, and M. D. Ginsberg. 1988. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51 (5): 1455-1464.
41. Rothman, S. M. 1983. Synaptic activity mediates death of hy-poxic neurons. Science 220: 536-537.
42. Choi, D. W. 1987. Ionic dependence of glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7: 369-379.
43. Palmer, G. C., E. F. Cregan, A. R. Borrelli, and F. Willett. 1995. Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride. Ann. N. Y. Acad. Sci. 765: 236-247.
44. Ikonomidou, C., and L. Turski. 1995. Excitotoxicity and neurodegenerative diseases. Curr. Opin. Neurol. 8: 487-497.
45. Meldrum, B. S. 1990. Protection against ischemia neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2: 27-57.
46. Pak, C. W., and M. C. Currás. 1998. Resistance to NMDA excitotoxicity is shown by supraoptic neurons of the hypothalamus in vitro. Soc. Neurosci. Abstr. 24(1): 464.
47. Pak, C. W., and M. C. Currás-Collazo. 2000. Resistance of supraoptic neurons to glutamate excitotoxicity may be partially due to enhanced glutamate clearance. FASEB J. 14(4): A633.
48. Pak, C. W., M. C. Curras-Collazo, and R. B. Meeker. 2001. Mechanism of excitotoxic resistance in supraoptic neurons may involve higher tolerance to calcium load. Soc. Neurosci. Abstr. 27: Program 178.4.
49. Currás, M. C., P. Rack, and R. B. Meeker. 1998. Channel properties of NMDA glutamate receptors on magnocellular neu-roendocrine cells cultured from the rat supraoptic nucleus. Brain Res. 789: 181-193.
50. Hu, B., and C. W. Bourque. 1991. Functional N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors are expressed by rat supraoptic neurosecretory cells in vitro. J.Neuroendocrinol. 3(5): 509-514.
51. Niiro, M., R. P. Simon, K. Kadota, and T. Asakura. 1996. Proximal branching patterns of middle cerebral artery (MCA) in rats and their influence on the infarct size produced by MCA occlusion. J. Neurosci. Methods 64: 19-23.
52. Fox, G., D. Gallacher, S. Shevde, J. Loftus, and G. Swayne. 1993. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke 24: 2087-2093.
53. Shigeno, T., J. McCulloch, D. I. Graham, A. D. Mendelow, and G. M. Teasdale. 1985. Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences. Surg. Neurol. 24(1): 47-51.
54. Chen, S. T., C. Y. Hsu, E. L. Hogan, H. Maricq, and J. D. Balentine. 1986. A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 17: 738-743.
55. Brint, S., M. Jacewicz, M. Kiessling, J. Tanabe, and W. Pulsinelli. 1988. Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8: 474-485.
56. Rubino, G. J., and W. Young. 1988. Ischemic cortical lesions after permanent occlusion of individual middle cerebral artery branches in rats. Stroke 19(7): 870-877.
57. Memenzawa, H., M. L. Smith, and B. K. Siesjo. 1992. Penumbral tissues salvaged by reperfusion following middle cerebral artrery occlusion in rats. Stroke 23: 552-559.
58. Ambach, G., and M. Palkovits. 1979. The blood supply of the hypothalamus in the rats. In Handbook of the Hypothalamus - Anatomy of the Hypothalamus, (P.J. Morgane and J. Panksepp, Eds.), Marcel Dekker, Inc., New York. pp. 267-377.
59. Paxinos, G., and C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.